Molecule Details
| InChIKey | YNZFUWZUGRBMHL-UHFFFAOYSA-N |
|---|---|
| Compound Name | Opipramol |
| Canonical SMILES | OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 8.45 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB12930 |
|---|---|
| Drug Name | Opipramol |
| CAS Number | 315-72-0 |
| Groups | investigational |
| ATC Codes | N06AA05 |
| Description | Opipramol has been used in trials studying the treatment of Dementia, Depression, Schizophrenia, Anxiety Disorders, and Psychosomatic Disorders. |
Categories: Adrenergic Agents Agents that produce hypertension Agents that reduce seizure threshold Antidepressive Agents Antidepressive Agents, Tricyclic Central Nervous System Agents Central Nervous System Depressants Dibenzazepines Heterocyclic Compounds, Fused-Ring Membrane Transport Modulators Narrow Therapeutic Index Drugs Nervous System Neurotoxic agents Neurotransmitter Agents Neurotransmitter Uptake Inhibitors Non-Selective Monoamine Reuptake Inhibitors Psychoanaleptics Psychotropic Drugs Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
Cross-references: BindingDB: 50170636 ChEBI: 94614 CHEMBL370753 ChemSpider: 9046 PharmGKB: PA144614922 PubChem:9417 PubChem:347829075 RxCUI: 7674 Wikipedia: Opipramol ZINC: ZINC000021981303